Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Protein-protein Interfaces

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Protein Networks

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Comparative predictive performance of computed tomography scoring systems in traumatic brain injury: a systematic review, Bayesian comparison, and meta-analysis.

Neurosurgical review·2026

Same author

A circadian checkpoint relocates neutrophils to minimize injury.

The Journal of experimental medicine·2025

Same author

A phase I trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of intravenously administered low-anticoagulant heparin (M6229) in critically ill sepsis patients.

Intensive care medicine experimental·2025

Same author

Trp1250, Lys1252, and Arg1367 of ADAMTS13 comprise a hot spot for anti-CUB domain antibodies in patients with iTTP.

Blood advances·2025

Same author

Buffer 4-Ethylmorpholinium/Acetate: Exploring a New Alternative Buffer for Native Mass Spectrometry.

Rapid communications in mass spectrometry : RCM·2025

Same author

Proteolytic neutralization of extracellular histones by neutrophil elastase is enhanced by heparin.

Journal of thrombosis and haemostasis : JTH·2025

Same journal

Von Willebrand disease: A century of progress.

Research and practice in thrombosis and haemostasis·2026

Same journal

Mechanism and kinetics study of MG1113, an anti-tissue factor pathway inhibitor antibody promoting hemostasis in hemophilia.

Research and practice in thrombosis and haemostasis·2026

Same journal

Resolving the dilution paradox to improve the interpretation of extracellular vesicle biomarker studies.

Research and practice in thrombosis and haemostasis·2026

Same journal

Heparin to prevent recurrent placenta-mediated pregnancy complications in women with antiphospholipid syndrome: a systematic review.

Research and practice in thrombosis and haemostasis·2026

Same journal

Thromboembolic ischemic stroke induces neutrophil recruitment and matrix metalloproteinase-9 release to enhance ischemic brain injury.

Research and practice in thrombosis and haemostasis·2026

Same journal

Real-world investigation of platelet apoptosis for mechanistic insights into severe immune thrombocytopenia and bleeding.

Research and practice in thrombosis and haemostasis·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 24, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Structural bioinformatics for rational drug design.

Soroush Mozaffari¹, Agnethe Moen¹, Che Yee Ng²

¹Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands.

Research and Practice in Thrombosis and Haemostasis

|March 3, 2025

Summary

This summary is machine-generated.

Structural bioinformatics and artificial intelligence are revolutionizing drug discovery. These computational methods accelerate the identification and optimization of drug candidates, making the process more efficient and cost-effective.

Keywords:

artificial intelligence computer-aided molecular design drug discovery machine learning molecular docking molecular dynamics simulation

More Related Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

Related Experiment Videos

Last Updated: May 24, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

Area of Science:

Computational chemistry
Bioinformatics
Drug discovery

Background:

Drug discovery is a lengthy, costly process.
Advancements in bioinformatics and cheminformatics are transforming the field.
Computational methods are increasingly vital for modern therapeutic development.

Purpose of the Study:

To review the state-of-the-art in structural bioinformatics for rational drug design.
To examine the impact of computational technologies on the drug development pipeline.
To highlight future directions and address limitations in computational drug discovery.

Main Methods:

Structure- and ligand-based virtual screening.
Molecular dynamics simulations.
Artificial intelligence (AI)-driven predictive models.

Main Results:

Computational methods significantly enhance the accuracy and efficiency of exploring chemical spaces and optimizing drug candidates.
AI and physics-based simulations improve predictions of binding affinity and toxicity.
These technologies accelerate lead compound identification and refinement.

Conclusions:

Structural bioinformatics and AI are indispensable tools in rational drug design, complementing experimental approaches.
Despite challenges in accuracy and interpretability, computational methods are crucial for informed decision-making in early drug discovery.
Successful applications demonstrate the potential of these technologies in developing novel inhibitors.